Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1983 Nov;72(5):1833–1838. doi: 10.1172/JCI111143

Influence of augmented Hageman factor (Factor XII) titers on the cryoactivation of plasma prorenin in women using oral contraceptive agents.

E M Gordon, J Douglas, O D Ratnoff
PMCID: PMC370472  PMID: 6355187

Abstract

Prolonged cold storage of plasma may induce the conversion of plasma prorenin (inactive renin) to renin. This phenomenon is exaggerated in oral contraceptive (OC) users; the titer of Hageman factor (HF, Factor XII) in OC users is higher than in nonusers. The present study relates these observations. The increment in plasma renin activity (PRA) during cold storage, as measured by generation of angiotensin I, correlated strongly with the initial plasma titer of HF. Increasing the HF titer of nonusers to that observed in OC users by addition of purified HF increased cold-induced PRA at least twofold, while reducing the plasma HF titer of OC users correspondingly decreased cold-induced PRA. Thus, in OC users, the enhanced conversion of plasma prorenin to renin during cold storage reflects the elevated plasma titer of HF.

Full text

PDF
1833

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blumberg A. L., Sealey J. E., Atlas S. A., Laragh J. H., Dharmgrongartama B., Kaplan A. P. Contact activation of human plasma prorenin in vitro. J Lab Clin Med. 1981 Jun;97(6):771–778. [PubMed] [Google Scholar]
  2. Cochrane C. G., Wuepper K. D. The first component of the kinin-forming system in human and rabbit plasma. Its relationship to clotting factor XII (Hageman Factor). J Exp Med. 1971 Oct 1;134(4):986–1004. doi: 10.1084/jem.134.4.986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Derkx F. H., Bouma B. N., Schalekamp M. P., Schalekamp M. A. An intrinsic factor XII- prekallikrein-dependent pathway activates the human plasma renin-angiotensin system. Nature. 1979 Jul 26;280(5720):315–316. doi: 10.1038/280315a0. [DOI] [PubMed] [Google Scholar]
  4. Derkx F. H., von Gool J. M., Wenting G. J., Verhoeven R. P., Man in 't Veld A. J., Schalekamp M. A. Inactive renin in human plasma. Lancet. 1976 Sep 4;1(7984):496–499. doi: 10.1016/s0140-6736(76)90791-1. [DOI] [PubMed] [Google Scholar]
  5. Forbes C. D., Pensky J., Ratnoff O. D. Inhibition of activated Hageman factor and activated plasma thromboplastin antecedent by purified serum C1 inactivator. J Lab Clin Med. 1970 Nov;76(5):809–815. [PubMed] [Google Scholar]
  6. Forbes C. D., Ratnoff O. D. Studies on plasma thromboplastin antecedent (factor XI), PTA deficiency and inhibition of PTA by plasma: pharmacologic inhibitors and specific antiserum. J Lab Clin Med. 1972 Jan;79(1):113–127. [PubMed] [Google Scholar]
  7. Gordon E. M., Donaldson V. H., Saito H., Su E., Ratnoff O. D. Reduced titers of Hageman factor (factor XII) in Orientals. Ann Intern Med. 1981 Dec;95(6):697–700. doi: 10.7326/0003-4819-95-6-697. [DOI] [PubMed] [Google Scholar]
  8. Gordon E. M., Ratnoff O. D., Jones P. K. The role of augmented Hageman factor (factor XII) titers in the cold-promoted activation of factor VII and spontaneous shortening of the prothrombin time in women using oral contraceptives. J Lab Clin Med. 1982 Mar;99(3):363–369. [PubMed] [Google Scholar]
  9. Gordon E. M., Ratnoff O. D., Saito H., Donaldson V. H., Pensky J., Jones P. K. Rapid fibrinolysis, augmented Hageman factor (factor XII) titers, and decreased C1 esterase inhibitor titers in women taking oral contraceptives. J Lab Clin Med. 1980 Nov;96(5):762–769. [PubMed] [Google Scholar]
  10. Hara A., Matsunaga M., Yamamoto J., Morimoto K., Nagai H., Pak C. H., Kanatsu K., Ogino K., Kawai C. Cryoactivation of inactive renin in human plasma. Jpn Circ J. 1979 Sep;43(9):827–836. doi: 10.1253/jcj.43.827. [DOI] [PubMed] [Google Scholar]
  11. Hedlin A. M., Loh A. Y., Osmond D. H. Fibrinolysis, renin activity, and prorenin in normal women: effects of exercise and oral contraceptive medication. J Clin Endocrinol Metab. 1979 Nov;49(5):663–671. doi: 10.1210/jcem-49-5-663. [DOI] [PubMed] [Google Scholar]
  12. Hojima Y., Pierce J. V., Pisano J. J. Hageman factor fragment inhibitor in corn seeds: purification and characterization. Thromb Res. 1980 Oct 15;20(2):149–162. doi: 10.1016/0049-3848(80)90381-3. [DOI] [PubMed] [Google Scholar]
  13. LEVY L. R., LEPOW I. H. Assay and properties of serum inhibitor of C'l-esterase. Proc Soc Exp Biol Med. 1959 Aug-Sep;101:608–611. doi: 10.3181/00379727-101-25034. [DOI] [PubMed] [Google Scholar]
  14. Osmond D. H., Cooper R. M. Cryoactivation and tryptic activation of blood 'prorenin' in normal man and animals. Can J Physiol Pharmacol. 1978 Oct;56(5):792–805. doi: 10.1139/y78-125. [DOI] [PubMed] [Google Scholar]
  15. Osmond D. H., Loh A. Y. Protease as endogenous activator of inactive renin. Lancet. 1978 Jan 14;1(8055):102–102. doi: 10.1016/s0140-6736(78)90047-8. [DOI] [PubMed] [Google Scholar]
  16. Osmond D. H., Ross L. J., Scaiff K. D. Increased renin activity after cold storage of human plasma. Can J Physiol Pharmacol. 1973 Sep;51(9):705–708. doi: 10.1139/y73-107. [DOI] [PubMed] [Google Scholar]
  17. RATNOFF O. D., DAVIE E. W. The purification of activated Hageman factor (activated factor XII). Biochemistry. 1962 Nov;1:967–975. doi: 10.1021/bi00912a005. [DOI] [PubMed] [Google Scholar]
  18. Ratnoff O. D., Pensky J., Ogston D., Naff G. B. The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C'1r subcomponent of the first component of complement by serum C'1 esterase inhibitor. J Exp Med. 1969 Feb 1;129(2):315–331. doi: 10.1084/jem.129.2.315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Ratnoff O. D. The relative amidolytic activity of Hageman factor (factor XII) and its fragments. The effect of high-molecular-weight kininogen and kaolin. J Lab Clin Med. 1980 Aug;96(2):267–277. [PubMed] [Google Scholar]
  20. Saito H., Ratnoff O. D., Donaldson V. H., Haney G., Pensky J. Inhibition of the adsorption of Hagemen factor (Factor XII) to glass by normal human plasma. J Lab Clin Med. 1974 Jul;84(1):62–73. [PubMed] [Google Scholar]
  21. Sealey J. E., Moon C., Laragh J. H., Alderman M. Plasma prorenin: cryoactivation and relationship to renin substrate in normal subjects. Am J Med. 1976 Nov;61(5):731–738. doi: 10.1016/0002-9343(76)90154-6. [DOI] [PubMed] [Google Scholar]
  22. Skinner S. L., Cran E. J., Gibson R., Taylor R., Walters W. A., Catt K. J. Angiotensins I and II, active and inactive renin, renin substrate, renin activity, and angiotensinase in human liquor amnii and plasma. Am J Obstet Gynecol. 1975 Mar 1;121(5):626–630. doi: 10.1016/0002-9378(75)90463-9. [DOI] [PubMed] [Google Scholar]
  23. Tatemichi S. R., Osmond D. H. Factor XII in endogenous activation of inactive renin. Lancet. 1978 Jun 17;1(8077):1313–1313. doi: 10.1016/s0140-6736(78)91298-9. [DOI] [PubMed] [Google Scholar]
  24. Zimmerman T. S., Ratnoff O. D., Powell A. E. Immunologic differentiation of classic hemophilia (factor 8 deficiency) and von Willebrand's dissase, with observations on combined deficiencies of antihemophilic factor and proaccelerin (factor V) and on an acquired circulating anticoagulant against antihemophilic factor. J Clin Invest. 1971 Jan;50(1):244–254. doi: 10.1172/JCI106480. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES